Sponsored Links
| WorldHeart Receives IRB Approval At First Center In The Levacor(TM) VAD BTT Clinical Trial |
 |
 |
 |
| Medical News - Heart Disease | |||
|
("WorldHeart"; Nasdaq: WHRT) - World Heart Corporation (WorldHeart) announced that the Levacor Ventricular Assist Device (VAD) Bridge-to-Transplant (BTT) Study has been approved by the Institutional Review Board (IRB) at INTEGRIS Baptist Medical Center in Oklahoma City. On-site clinical and technical training has been conducted, formally qualifying this center as the first for the Levacor Study. Dr. Read more: Heart Disease News From Medical News Today
|